<DOC>
	<DOCNO>NCT00930215</DOCNO>
	<brief_summary>The purpose study determine whether HPMC capsule D961H 40 mg bioequivalent gelatine capsule D961H 40 mg steady state reach Day 5</brief_summary>
	<brief_title>Study Comparing Gelatine Capsule 40 mg D961H HPMC Capsule Japanese Healthy Males</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese Classified homoEM Negative HIV , Hepatitis B , Hepatitis C syphilis Significant clinical illness 2 week precede preentry visit randomization Past present cardiac , renal , hepatic , neurological gastrointestinal disease</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Japanese male</keyword>
	<keyword>homo-EM</keyword>
	<keyword>Bioequivalence study</keyword>
</DOC>